CION Ameerpet
Radiation Therapy · Scan & Report Explainers
MRI Perfusion and Spectroscopy After Brain Radiation — What Those Extra Sequences Are Looking For
Medically reviewed by Dr. Venkata Sushma P, Radiation Oncologist, MBBS · MD (Radiation Oncology) · Last reviewed August 2026
Your follow-up brain MRI came back with words nobody explained — perfusion, spectroscopy, rCBV, a Cho/NAA ratio. These are extra sequences added to your usual scan because a standard MRI often cannot separate treated tissue that is breaking down from tumour that is growing back. This page explains what each sequence measures, what the two are trying to tell apart, and why neither settles the question on its own. It explains the terminology only — your own report belongs to your treating team to read.
- The extra sequences exist for one reason — a standard contrast MRI can show treatment effect and returning tumour in the same place, looking almost the same.
- Perfusion measures blood, spectroscopy measures chemistry — two independent readings of the same area, which is why they are usually ordered together.
- Neither is a stand-alone test — NCCN and ASTRO describe them as supporting information, read with your timeline, earlier scans and symptoms.
- Your scan is done at an NABH-accredited partner centre — CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
Why has my brain MRI added perfusion and spectroscopy sequences?
Because a standard MRI after brain radiation often cannot tell two very different things apart. Treated tissue that is breaking down and tumour that is growing back can both light up in the same place, in the same way. Perfusion and spectroscopy add blood-flow and chemical information a plain contrast scan does not carry.
A routine post-radiation MRI shows shape, size and enhancement. Enhancement means the contrast injection has leaked into an area where the blood-brain barrier is disrupted. Radiation disrupts that barrier. So does a returning tumour. On appearance alone, the two can look almost identical for months.
Perfusion looks at how much blood is moving through the area. Spectroscopy looks at which chemical signals the area is producing. Neither replaces your standard sequences. Both are added on top of them, in the same session, to give your team more to work with.
This page explains what these sequences are and what the words on the report mean. It does not interpret any individual scan. Only your treating team, with your images and your history in front of them, can say what your own report shows.
Sequence by sequence
What does each MRI sequence actually add?
These are the general purposes of each sequence. Which ones your centre runs, and in what combination, depends on your case and your radiologist’s protocol.
| Sequence | What it measures | What it helps answer |
|---|---|---|
| Standard T1 with contrast | Where the contrast injection leaks into tissue | Where the abnormal area is, and how big it is |
| T2 / FLAIR | Fluid and swelling in and around the area | How much swelling surrounds the lesion |
| MR perfusion | How much blood volume and flow the area carries | Whether the area is building its own blood supply |
| MR spectroscopy | The chemical signals coming from the tissue | Whether the chemistry looks like living cells or breakdown |
| Diffusion (DWI / ADC) | How freely water moves through the tissue | How densely packed the cells in the area are |
Did you know?
Changes that mimic a growing tumour on a brain MRI most often appear within the first three months after chemoradiation, then settle on their own. Neuro-oncology teams call this pseudoprogression. It is one reason NCCN Central Nervous System Cancers guidance, current as of 2026, describes advanced sequences such as perfusion and spectroscopy as helpful additions rather than stand-alone tests, and recommends reading them alongside your treatment timeline and your earlier scans.
The question behind the scan
What are perfusion and spectroscopy trying to tell apart?
They are trying to separate treatment effect from returning tumour. Treatment effect is damaged, dying tissue where the radiation was delivered. Returning tumour is living cancer cells growing again. Both can enhance on a standard scan, in the same spot, at the same point after treatment.
The reasoning behind each sequence is different, and simple to follow.
A growing tumour generally builds new blood vessels to feed itself. On perfusion, that tends to show as higher blood volume in the area. Damaged, treated tissue is not building a blood supply. On perfusion, it tends to show as low or reduced blood volume.
Spectroscopy works on chemistry instead. Signals linked to active cell-membrane turnover tend to rise where cells are multiplying. Signals linked to healthy nerve tissue tend to fall in both situations. Signals linked to tissue breakdown tend to dominate where tissue is dying rather than growing.
Put together, the two sequences pull in the same direction more often than either does alone. That is why they are usually ordered together rather than one at a time.
If the phrase “necrosis versus recurrence” is what brought you here, our companion page on radiation necrosis versus recurrence covers the clinical picture. This page is the technical half: what the scan is actually measuring.
The honest limit
Are perfusion and spectroscopy conclusive on their own?
No. Neither sequence gives a yes-or-no answer by itself. Both narrow the possibilities, and both can point the wrong way. Guideline bodies including NCCN and ASTRO describe them as supporting information, read alongside your timeline, your earlier scans and your symptoms, rather than as a stand-alone test.
There are several reasons a single scan may not settle the question.
Many lesions are mixed. Dying treated tissue and living tumour cells can sit inside the same area, so one measurement averages both together.
The numbers are not standardised. Thresholds for what counts as a high or a low value vary between scanners, software and centres, so a value from one hospital does not transfer cleanly to another.
Small areas are hard to measure. Spectroscopy needs a certain volume of tissue to sample, so a tiny lesion may not give a reliable reading at all.
Other things interfere. Bleeding inside the lesion, nearby bone or air, and medicines your team may have prescribed to reduce swelling can all shift what the sequences show.
When the picture stays uncertain, the usual next step is not a bigger scan. It is a repeat MRI after a defined interval, to see which way the area moves over time, and occasionally a biopsy — a decision your treating team makes with you.
Nothing on this page should be read as applying to your own scan. Bring your report to your team and ask them directly what it means for you.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get your own brain MRI report explained, sequence by sequence
A radiation oncologist can walk you through what perfusion and spectroscopy mean in your own report. Free, confidential, no commitment to start treatment.
On the day
What happens during an MRI with perfusion and spectroscopy?
The extra sequences are added to the same appointment. You are not booked for two separate scans.
Your standard sequences run first
The scan begins the way any brain MRI does, building the structural images your radiologist compares against your earlier scans.
A contrast injection is given through a cannula
A small line is placed in your arm beforehand. Perfusion is timed around this injection, which is why the cannula goes in before the scan starts rather than partway through.
Perfusion images are captured as the contrast passes through
The scanner takes rapid images while the contrast moves through the blood vessels in your brain, measuring how much reaches the area of interest.
Spectroscopy samples a defined block of tissue
The radiographer positions one or more sampling boxes over the area and comparable normal tissue. This step needs you to stay still and usually adds several minutes.
The data is processed into maps and graphs
Perfusion becomes a colour map. Spectroscopy becomes a graph of peaks. Neither is read off the screen during your scan — both are processed afterwards.
Your radiologist reports it against your earlier scans
The report goes to your treating team, who read it together with your treatment dates, your symptoms and your previous imaging before discussing it with you.
The words on your report
What do the terms on a perfusion and spectroscopy report mean?
These are general definitions of the terminology. They are not a key for reading your own values — that is your treating team’s job.
Perfusion
rCBV
Relative cerebral blood volume. A comparison of how much blood the area of interest holds against normal-looking brain tissue elsewhere in your scan.
Perfusion
Ktrans / permeability
A measure of how leaky the small blood vessels in the area are. Reported by some centres alongside blood volume, depending on the perfusion technique used.
Spectroscopy
Cho (choline) peak
A signal linked to cell-membrane turnover. It tends to rise where cells are actively multiplying.
Spectroscopy
NAA peak
N-acetylaspartate, a signal produced by healthy nerve tissue. It tends to fall wherever normal brain tissue has been replaced or damaged.
Spectroscopy
Cho/NAA and Cho/Cr ratios
Ratios comparing the choline peak against nerve-tissue and reference peaks. Ratios are reported rather than raw heights because raw values are not comparable between scans.
Spectroscopy
Lipid-lactate peak
A signal associated with tissue breakdown and low oxygen. Its presence is one of the findings a radiologist weighs when treatment effect is under consideration.
Timing
Pseudoprogression
An apparent increase in enhancement soon after chemoradiation that settles on its own. It is a timing pattern, not a separate disease.
Timing
Radiation necrosis
Late breakdown of treated tissue in the radiation field, typically appearing months to years after treatment rather than in the first weeks.
Putting it together
Reading a sample MRI report line, term by term
Illustrative wording only, to show how a report is structured. Bring your own report to your consultation and a radiation oncologist will go through your exact wording with you.
| What you might see | What the phrase means |
|---|---|
| Enhancing lesion within the radiation field | An area taking up contrast that sits inside the region that was treated |
| rCBV reduced relative to contralateral white matter | The area holds less blood than matching tissue on the other side of the brain |
| Elevated Cho/NAA ratio within the voxel | Inside the sampled block of tissue, the cell-turnover signal is high relative to the nerve-tissue signal |
| Prominent lipid-lactate peak | A strong signal associated with tissue breakdown and low oxygen in the sampled area |
| Findings are non-specific; correlate clinically | The imaging alone does not settle the question — your treating team must read it with your symptoms and history |
| Recommend short-interval follow-up MRI | A repeat scan sooner than usual, to see which way the area moves over time |
You do not have to decode this alone
One conversation can make your MRI report make sense
Whether your scan was last week or you are years into follow-up, a radiation oncologist can explain your own perfusion and spectroscopy findings in plain language.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Perfusion, spectroscopy and your MRI report — questions answered
Why has my brain MRI added perfusion and spectroscopy sequences?
Because a standard MRI after brain radiation often cannot tell two very different things apart. Treated tissue that is breaking down and tumour that is growing back can both take up contrast in the same place, in the same way, for months after treatment. A plain contrast scan shows shape, size and enhancement, but not why an area is enhancing. Perfusion adds information about how much blood is moving through the area. Spectroscopy adds information about the chemical signals the tissue is producing. Both are run in the same appointment, on top of your standard sequences, to give your treating team more to work with when the structural images alone are not enough.
What are MR perfusion and MR spectroscopy trying to tell apart?
They are trying to separate treatment effect from returning tumour. Treatment effect is damaged, dying tissue in the area that was irradiated. Returning tumour is living cancer cells growing again. A growing tumour generally builds new blood vessels to feed itself, which on perfusion tends to show as higher blood volume in the area, while damaged treated tissue tends to show low or reduced blood volume. Spectroscopy looks at chemistry instead: signals linked to cell-membrane turnover tend to rise where cells are multiplying, while signals linked to tissue breakdown tend to dominate where tissue is dying. The two sequences are usually ordered together because they support each other.
Are perfusion and spectroscopy conclusive on their own?
No. Neither sequence gives a yes-or-no answer by itself, and both can point the wrong way. Guideline bodies including NCCN and ASTRO describe advanced sequences as supporting information, read alongside your treatment timeline, your earlier scans and your symptoms, rather than as a stand-alone test. Several things limit them. Many lesions are mixed, with dying tissue and living tumour cells inside the same area. Thresholds are not standardised between scanners, software and centres. Small lesions may be too small for spectroscopy to sample reliably. Bleeding, nearby bone or air, and medicines prescribed to reduce swelling can all shift the readings. When the picture stays unclear, a repeat scan after an interval, or occasionally a biopsy, is the usual next step.
What do rCBV and the Cho/NAA ratio mean on my report?
rCBV stands for relative cerebral blood volume. It compares how much blood the area of interest holds against normal-looking brain tissue elsewhere on the same scan, which is why it is reported as a comparison rather than an absolute number. Cho is the choline peak, a signal linked to cell-membrane turnover that tends to rise where cells are actively multiplying. NAA is N-acetylaspartate, a signal produced by healthy nerve tissue that tends to fall where normal brain has been damaged or replaced. The Cho/NAA ratio compares the two. Ratios are reported rather than raw peak heights because raw values are not comparable between scans or scanners. These are general definitions only, not a key for reading your own values.
Does the scan take longer, and do I need to do anything differently?
It is one appointment, not two, but it does usually run longer than a routine brain MRI. A cannula is placed in your arm before the scan, because perfusion images are timed around the contrast injection and cannot be added partway through. Spectroscopy needs you to lie still while the scanner samples one or more defined blocks of tissue, which typically adds several minutes to the session. Nothing is read off the screen while you are in the scanner: perfusion becomes a colour map and spectroscopy becomes a graph of peaks, both processed afterwards. Your radiologist then reports the findings against your earlier scans, and your treating team discusses them with you.
Where is my brain MRI actually performed?
Your MRI is performed and reported at an NABH-accredited partner centre equipped for advanced neuro-imaging. CION Cancer Clinics coordinates the care around that scan: arranging the appointment, receiving the report, and walking you through what the terminology means. Your radiotherapy is delivered at an NABH-accredited partner centre, and CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate the imaging or radiotherapy equipment itself. What you get from CION is a dedicated oncology team that stays with you across scans, reports and follow-up, so the words on your report are explained by someone who knows your case.
This page explains general MRI reporting terminology after brain radiation. It is not a substitute for your own treating team's interpretation of your specific report, diagnosis and treatment plan.